QA: G1 Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001560241_2021_G1_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001560241, G1 Therapeutics Inc

  xvar xval
0 AssetsCurrent 216,392,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,482,000
3 remainder_Assets 9,678,000
4 LiabilitiesCurrent 23,443,000
5 LiabilitiesNoncurrent 7,865,000
6 remainder_Liabilities 19,893,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 210,721,550
9 ResearchAndDevelopmentExpense 67,673,356
10 remainder_Expenses 1,410,000
11 remainder_Revenues 45,285,000
12 remainder_NetIncome 1,671,759
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 228,552,000
1 Liabilities 51,201,000
2 Expenses 279,804,906
3 Revenues 45,285,000
4 StockholdersEquity 177,351,000
5 NetIncome -232,848,147
6 ComprehensiveNetIncome -232,848,147
7 BaseVar 303,257,332
8 EconomicCapitalRatiobeforeLimitedLiability 1.10
9 EconomicCapitalRatio 2.38

Edgar->Model Mapping

Feature Distribution

Change over Time